CHMP recommends Merck, Sharp and Dohme's Ivemend for nausea with chemotherapy Nov. 21, 2007 No Comments
Bausch & Lomb Ireland withdraws Retisert marketing authorization application July 27, 2007 No Comments
Ariad receives FDA feedback on pivotal study of AP-23573 for metastatic sarcoma April 11, 2007 No Comments
RSS